Skip to main content
Erschienen in: Child's Nervous System 8/2014

01.08.2014 | Original Paper

Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors

verfasst von: Matthias Preuss, Peter Werner, Henryk Barthel, Ulf Nestler, Holger Christiansen, Franz Wolfgang Hirsch, Dominik Fritzsch, Karl-Titus Hoffmann, Matthias K. Bernhard, Osama Sabri

Erschienen in: Child's Nervous System | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

An integrated PET/MRI scanner has been used in selected cases of pediatric brain tumor patients to obtain additional metabolic information about lesions for preoperative biopsy planning and navigation.

Patients and methods

Four patients, age 9–16 years, received PET/MRI scans employing [11C]methionine positron emission tomography (PET) and contrast-enhanced 3D-MR sequences for neuronavigation. PET and MR sequences have been matched for neurosurgical guidance. An infrared camera-based neuronavigation system was employed with co-registered MR and PET images fused to hybrid images for preoperative planning, stereotactic biopsy planning, and/or intraoperative guidance.

Results

All patients showed hot spots of increased amino acid transport in PET and contrast-enhancing lesions in MRI. In three of the four patients, PET hot spots were congruent with contrast-enhancing areas in MRI. In two patients, frame-based stereotactic biopsies were taken from thalamo-mesencephalic lesions. One patient underwent second-look surgery for the suspicion of recurrent malignant glioma of the posterior fossa. One incidental frontal mass lesion was subtotally resected. No complications occurred. Hybrid imaging was helpful during the procedures to obtain representative histopathologic specimens and for surgical guidance during resection. Co-registered images did match with intraoperative landmarks, tumor borders, and histopathologic specimens.

Conclusion

The integrated PET/MRI scanner offers co-registered multimodal, high-resolution data for neuronavigation with reduced radiation exposure compared to PET/CT scans. One examination session provides all necessary data for neuronavigation and preoperative planning, avoiding additional anesthesia in the small patients. Hybrid multimodality imaging may improve safety and yield additional information when obtaining representative histopathologic specimens of brain tumors.
Literatur
1.
Zurück zum Zitat Bailey DL, Barthel H, Beyer T, Boellaard R, Gückel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF (2012) Summary report of the first international workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol 15(4):361–371CrossRef Bailey DL, Barthel H, Beyer T, Boellaard R, Gückel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF (2012) Summary report of the first international workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol 15(4):361–371CrossRef
2.
Zurück zum Zitat Biermann M, Schwarzlmüller T, Fasmer KE, Reitan BC, Johnsen B, Rosendahl K (2013) Is there a role for PET-CT and SPECT-CT in pediatric oncology? Acta Radiol 54(9):1037–1045. doi:10.1258/ar.2012.120616, Epub 2013 Apr 30. ReviewPubMedCrossRef Biermann M, Schwarzlmüller T, Fasmer KE, Reitan BC, Johnsen B, Rosendahl K (2013) Is there a role for PET-CT and SPECT-CT in pediatric oncology? Acta Radiol 54(9):1037–1045. doi:10.​1258/​ar.​2012.​120616, Epub 2013 Apr 30. ReviewPubMedCrossRef
3.
Zurück zum Zitat Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43(7):860–875. doi:10.1007/s00247-012-2570-4, Epub 2013 Jan 11PubMedCentralPubMedCrossRef Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43(7):860–875. doi:10.​1007/​s00247-012-2570-4, Epub 2013 Jan 11PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Imani F, Boada FE, Lieberman FS, Davis DK, Deeb EL, Mountz JM (2012) Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging 22(2):184–190PubMedCentralPubMedCrossRef Imani F, Boada FE, Lieberman FS, Davis DK, Deeb EL, Mountz JM (2012) Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging 22(2):184–190PubMedCentralPubMedCrossRef
5.
6.
Zurück zum Zitat Mertens K, Acou M, Van Hauwe J, De Ruyck I, Van den Broecke C, Kalala JP, D’Asseler Y, Goethals I (2013) Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study. Clin Nucl Med 38(7):495–500. doi:10.1097/RLU.0b013e318292a753 PubMedCrossRef Mertens K, Acou M, Van Hauwe J, De Ruyck I, Van den Broecke C, Kalala JP, D’Asseler Y, Goethals I (2013) Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study. Clin Nucl Med 38(7):495–500. doi:10.​1097/​RLU.​0b013e318292a753​ PubMedCrossRef
7.
Zurück zum Zitat Pichler BJ, Kolb A, Nägele T, Schlemmer HP (2010) PET/MRI: paving the way for next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336PubMedCrossRef Pichler BJ, Kolb A, Nägele T, Schlemmer HP (2010) PET/MRI: paving the way for next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336PubMedCrossRef
8.
Zurück zum Zitat Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions. J Neurosurg Pediatr 5(5):479–485PubMedCrossRef Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions. J Neurosurg Pediatr 5(5):479–485PubMedCrossRef
9.
Zurück zum Zitat Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumor. J Neurosurg Pediatr 5(5):486–499PubMedCrossRef Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumor. J Neurosurg Pediatr 5(5):486–499PubMedCrossRef
10.
Zurück zum Zitat Sattler B, Jochimsen T, Barthel H, Sommerfeld K, Stumpp P, Hoffmann KT, Gutberlet M, Villringer A, Kahn T, Sabri O (2013) Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting. MAGMA 26(1):159–171PubMedCrossRef Sattler B, Jochimsen T, Barthel H, Sommerfeld K, Stumpp P, Hoffmann KT, Gutberlet M, Villringer A, Kahn T, Sabri O (2013) Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting. MAGMA 26(1):159–171PubMedCrossRef
11.
Zurück zum Zitat Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ (2010) Combined PET/MR: one step further in multimodality imaging. Trends Mol Med 16:508–515PubMedCrossRef Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ (2010) Combined PET/MR: one step further in multimodality imaging. Trends Mol Med 16:508–515PubMedCrossRef
12.
Zurück zum Zitat Thorsen F, Fite B, Mahakian LM, Seo JW, Qin S, Harrison V, Johnson S, Ingham E, Caskey C, Sundstrøm T, Meade TJ, Harter PN, Skaftnesmo KO, Ferrara KW (2013) Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release 172(3):812–822. doi:10.1016/j.jconrel.2013.10.019, Epub 2013 Oct 29PubMedCrossRef Thorsen F, Fite B, Mahakian LM, Seo JW, Qin S, Harrison V, Johnson S, Ingham E, Caskey C, Sundstrøm T, Meade TJ, Harter PN, Skaftnesmo KO, Ferrara KW (2013) Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release 172(3):812–822. doi:10.​1016/​j.​jconrel.​2013.​10.​019, Epub 2013 Oct 29PubMedCrossRef
13.
Zurück zum Zitat Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):56–68CrossRef Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):56–68CrossRef
14.
Zurück zum Zitat Wehrl HF, Schwab J, Hasenbach K, Reischl G, Tabatabai G, Quintanilla-Martinez L, Jiru F, Chughtai K, Kiss A, Cay F, Bukala D, Heeren RM, Pichler BJ, Sauter AW (2013) Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography. Cancer Res 73(5):1470–1480. doi:10.1158/0008-5472.CAN-12-2532, Epub 2013 Jan 23PubMedCrossRef Wehrl HF, Schwab J, Hasenbach K, Reischl G, Tabatabai G, Quintanilla-Martinez L, Jiru F, Chughtai K, Kiss A, Cay F, Bukala D, Heeren RM, Pichler BJ, Sauter AW (2013) Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography. Cancer Res 73(5):1470–1480. doi:10.​1158/​0008-5472.​CAN-12-2532, Epub 2013 Jan 23PubMedCrossRef
Metadaten
Titel
Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors
verfasst von
Matthias Preuss
Peter Werner
Henryk Barthel
Ulf Nestler
Holger Christiansen
Franz Wolfgang Hirsch
Dominik Fritzsch
Karl-Titus Hoffmann
Matthias K. Bernhard
Osama Sabri
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 8/2014
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-014-2412-9

Weitere Artikel der Ausgabe 8/2014

Child's Nervous System 8/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.